Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 6:47 PM
Ignite Modification Date: 2025-12-25 @ 4:18 PM
NCT ID: NCT04570657
Description: None
Frequency Threshold: 5
Time Frame: Day 1 to Week 24 (up to 24 weeks)
Study: NCT04570657
Study Brief: Study to Assess the Efficacy and Safety of MEDI3506 in Adults With Uncontrolled Moderate-to-severe Asthma
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Tozorakimab Dose A Participants were randomised to receive tozorakimab Dose A by subcutaneous (SC) injection. 0 None 1 77 25 77 View
Placebo Participants were randomised to receive placebo by SC injection. 0 None 2 81 20 81 View
Tozorakimab Dose B Participants were randomised to receive tozorakimab Dose B by SC injection. 0 None 4 77 20 77 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Bronchitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 25.1 View
Clostridium difficile colitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 25.1 View
Asthma SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 25.1 View
Acid peptic disease SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 25.1 View
Umbilical hernia SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 25.1 View
Asthenia SYSTEMATIC_ASSESSMENT General disorders MedDRA 25.1 View
Clavicle fracture SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA 25.1 View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
COVID-19 SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 25.1 View
Nasopharyngitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 25.1 View
Injection site erythema SYSTEMATIC_ASSESSMENT General disorders MedDRA 25.1 View
Urinary tract infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 25.1 View
Injection site swelling SYSTEMATIC_ASSESSMENT General disorders MedDRA 25.1 View
Injection site urticaria SYSTEMATIC_ASSESSMENT General disorders MedDRA 25.1 View